CAPITOL ASSOCIATES, INC. for JOINT COUNCIL OF ALLERGY ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
CoFAR and DOD Food Allergy Research Funding 2026 Appropriations
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASMINE GARNER New | — |
| MATTHEW A. REITER | — |
Medicare/Medicaid MMM
Medicare reimbursements for physicians Prior Authorization Reform H.R.2433 - Reducing Medically Unnecessary Delays in Care Act of 2025 Medicare Advantage burden reduction reform One Big Beautiful Bill Act S. 1105 - No Upcode Act Medicare coverage for allergy immunotherapy Protecting Approved Care Act Patients First Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASMINE GARNER New | — |
| MATTHEW A. REITER | — |
Health Issues HCR
Protecting Children with Food Allergies Act Telehealth coverage flexibilities Epinephrine costsharing for patients Asthma inhaler prices Cybersecurity requirements for medical practices No Fees for EFTs Act Supporting food allergy treatment innovations Smoke and Wildfire HR 903 One Big Beautiful Bill Act S.1816/H.R.3514 Coverage for allergy immunotherapy EPIPEN Act S. 222 Whole Milk for Healthy Kids Act Biosimilar/Biologic Approval Process
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASMINE GARNER | — |
| MATTHEW A. REITER | — |
Aviation/Airlines/Airports AVI
Epinephrine for anaphylaxis on commercial airline emergency medical kits
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASMINE GARNER | — |
| MATTHEW A. REITER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.